StreetInsider.com News Articles

Form PRE 14A CURIS INC For: Nov 18

Fri, 23 Oct 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20261023/27224855.html

Form 8-K CURIS INC For: Oct 16

Mon, 19 Oct 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20261019/27204307.html

Curis prices $8.5M private placement at $0.51 per share

Fri, 16 Oct 2026 08:00:33 -0400

Curis, Inc. (Nasdaq: CRIS), a Lexington, Mass.-based biotechnology company, announced it has entered into securities purchase agreements with existing healthcare-focused institutional investors for a private placement expected to raise approximately $8.5 million in gross proceeds, before placement agent fees and other expenses.

The offering includes 16,666,680 shares of common stock, or pre-funded warrants in lieu thereof, along with common warrants to purchase up to 16,666,680 additional shares. The combined price is $0.51 per share and accompanying common warrant. The common warrants carry an exercise price of $0.60 per share, become exercisable six months after issuance, and expire five and a half

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

Fri, 16 Oct 2026 08:00:00 -0400

LEXINGTON, Mass., Oct. 16, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into securities purchase agreements with certain existing healthcare focused institutional investors for the purchase and sale of 16,666,680 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

Fri, 16 Oct 2026 08:00:00 -0400

Form 10-Q CURIS INC For: Jun 30

Fri, 14 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260814/26930052.html

Form 10-Q CURIS INC For: Jun 30

Fri, 14 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260814/26930052.html

Form 424B4 CURIS INC

Thu, 13 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260813/26922874.html

Form 424B4 CURIS INC

Thu, 13 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260813/26922874.html

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on developing emavusertib, announced the pricing of a public offering expected to raise approximately $5.6 million in gross proceeds before fees and expenses.

The offering includes 3,733,334 shares of common stock, or pre-funded warrants in lieu thereof, paired with warrants to purchase up to 3,733,334 additional shares. The combined public offering price is $1.50 per share and accompanying common warrant, or $1.49 per pre-funded warrant and accompanying common warrant.

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis prices $5.6M public offering at $1.50 per share

Thu, 13 Aug 2026 08:01:17 -0400

The common warrants carry an exercise price of $1.75 per share, are exercisable immediately, and expire five years from the issuance date. The pre-funded warrants

Curis, Inc. Announces Pricing of $5.6 Million Public Offering